April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Rapamycin Reduces Reactive Oxygen Species in Cultured Human Corneal Endothelial Cells
Author Affiliations & Notes
  • DOO YOUNG CHO
    Ophthalmology, Hallym University College of Medicine, Seoul, Republic of Korea
  • Young Joo Shin
    Ophthalmology, Hallym University College of Medicine, Seoul, Republic of Korea
  • Jong Mo Seo
    Electrical Engineering, Seoul National University College of Engineering, Seoul, Republic of Korea
  • Tae Young Chung
    3Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • Joon Young Hyon
    Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea
  • Won Ryang Wee
    Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6454. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      DOO YOUNG CHO, Young Joo Shin, Jong Mo Seo, Tae Young Chung, Joon Young Hyon, Won Ryang Wee; Rapamycin Reduces Reactive Oxygen Species in Cultured Human Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6454.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the protective effect of rapamycin on oxidative stress-induced cell death of human corneal endothelial cells

Methods: : Human corneal endothelial cells (HCECs) were cultured according to previously published methods. With treatment of 0 mM or 5 mM of tert-butyl hydroperoxide (tBHP) with various concentrations (0, 25, and 50 nM) of rapamycin, reactive oxygen species (ROS) production was measured using an oxidation-sensitive fluorescent probe, 2'7'-dichlorofluorescin diacetate (DCFH-DA, USA) methods. Cell viability was assayed by the method of CCK-8 (Cell Counting Kit-8, Wako). The levels of cellular glutathione were also assessed enzymatically with glutathione reductase by using a commercial glutathione assay kit (Cayman Chemical, USA)

Results: : In vitro studies showed that rapamycin reduced 2',7'-dihydrodichlorofluorescein oxidation and increased glutathione. Rapamycin significantly inhibited tBHP-induced ROS production. Cells treated with rapamycin had higher viability compared to control at 5 mM tBHP and rapamycin effectively protected HCEC from ROS-induced cell death through increasing intracellular glutathione.

Conclusions: : Our data suggest that rapamycin protect HCEC at high concentrations from oxidative injury-mediated cell death via inhibition of ROS production.

Keywords: cornea: endothelium • oxidation/oxidative or free radical damage • drug toxicity/drug effects 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×